Similar Articles |
|
The Motley Fool January 11, 2005 Lawrence Meyers |
Israel at the Forefront Middle East peace could make Israeli stocks more appealing. |
The Motley Fool May 26, 2006 Michael Jaffe |
What the Oracle Saw in Israel Berkshire Hathaway announced its $4 billion acquisition of 80% of Israel's Iscar Metalworking. While Israelis appreciate this visible financial stamp of approval, there are compelling reasons why the deal should make Berkshire shareholders happy, too. |
The Motley Fool November 2, 2010 Eric Dutram |
Tuesday's ETF to Watch: iShares Israel ETF (EIS) TEVA reports earnings. |
BusinessWeek September 9, 2010 Bhaktavatsalam et al. |
Israel Gets an Upgrade, and Investors Depart Now that it's a developed market rather than an emerging one, Harvard, T. Rowe Price, and others are pulling out |
BusinessWeek September 26, 2005 |
Israel Shakes Up Its Banking Sector The Israeli government hopes to get out of the banking business by yearend. |
National Real Estate Investor September 1, 2004 Hortense Leon |
Israeli Investors Flock to South Florida When Africa-Israel Investments and Brooklyn developer Shaya Boymelgreen announced in July that they were planning to build $1.5 billion of residential and office development near downtown Miami and on South Beach, South Floridians took notice. |
The Motley Fool November 8, 2006 Todd Wenning |
This Is Not a Fad Unlike disco, international stocks are stayin' alive. |
The Motley Fool June 8, 2006 Chuck Saletta |
Stocks You Won't Sell If the companies you own pay you well, you may never need to sell them. |
The Motley Fool October 31, 2011 Igor Meyerson |
Why You Should Always Pay Attention to the Footnotes of a Financial Report When companies make changes in their financial reports they need to make it easier for individuals to spot them. |
The Motley Fool February 28, 2006 Stephen D. Simpson |
Still Waiting for Teva to Stumble This leading Israeli generics firm hasn't seen a stock pullback of any consequence since mid- to late 2004. And while fourth-quarter results weren't fabulous, they were good enough given the circumstances |
BusinessWeek July 2, 2007 Neal Sandler |
Israel: A Hotbed Of...Investment Amid tightened security, companies in Israel are thriving at home - and expanding abroad. |
The Motley Fool June 28, 2011 Eric Bleeker |
Where Is Teva Pharmaceuticals Finding Growth? Teva should see its sales continue to climb, especially in already booming international markets. |
The Motley Fool December 15, 2003 Mathew Emmert |
Warren, Show Me the Money Why Berkshire Hathaway should pay dividends. |
The Motley Fool May 11, 2011 Jared Cummans |
Wednesday's ETF to Watch: iShares MSCI Israel Fund Teva Pharmaceuticals releases earnings today. |
BusinessWeek May 31, 2004 Lauren Young |
One Way To Get New Investors Free mutual fund shares entice people to invest in Israel. |
The Motley Fool March 8, 2007 Chuck Saletta |
Dueling Fools: Berkshire Hathaway Bear Berkshire Hathaway trades at a premium to other insurers, is stingier to its shareholders than other conglomerates, and looks to be too cash-rich to invest its entire hoard successfully in the future. |
The Motley Fool May 5, 2007 Matt Koppenheffer |
Quick Take: The Questions Begin Buffett and Munger discuss private equity and overseas investing during the annual Berkshire Hathaway shareholder meeting. |
Chemistry World December 2, 2013 Maria Burke |
Compromise puts Israel on course to join Europe's science program Israel and the EU have resolved the diplomatic dispute that looked set to shut out Israeli research universities and technology companies from Europe's flagship science program. |
BusinessWeek May 2, 2005 |
Tensions Over Israeli Arms Sales To China Israeli arms deals with China are continuing to make waves in relations between Jerusalem and Washington. |
Chemistry World February 11, 2014 Emma Stoye |
Dan Shechtman starts presidential campaign Dan Shechtman, who won the chemistry Nobel in 2011 for his work on quasicrystals, has begun his campaign to become president of Israel, meeting with politicians at the Knesset, the legislative arm of Israel's government. |
The Motley Fool August 1, 2005 Stephen D. Simpson |
Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance. |
The Motley Fool November 7, 2007 Matt Koppenheffer |
Just Another Quarter for Berkshire When it comes to a solid group of businesses like those under the Berkshire umbrella, quarterly reports seem irrelevant. |
BusinessWeek December 20, 2004 |
Tightening Israeli-Egyptian Ties Four free-trade zones will be created in Egypt as a result of a deal to be signed by Israel, Egypt, and the U.S. on Dec. 14. |
The Motley Fool April 7, 2010 Rick Steier |
Is Teva Pharmaceutical a Forever Hold? Teva is a compelling reason why investors should look abroad for opportunity. |
The Motley Fool December 14, 2009 Rich Smith |
This Just In: Upgrades and Downgrades Piper Jaffray plays a wrong note on Teva. |
BusinessWeek March 7, 2005 |
A Banner Year For Israeli Arms Exports Israel's budding defense relationship with India continues to expand. |
BusinessWeek January 24, 2005 |
An American Chief For Israel's Central Bank Israel's financial markets welcomed the nomination of Citigroup Vice-Chairman Stanley Fischer as governor of the Bank of Israel, the country's central bank. The Tel Aviv stock index rose 1%, to an all-time high, after the decision was announced. |
InternetNews April 22, 2005 |
IBM Gets Israel in On Demand Start-up ISVs are the target of the latest program to promote on-demand computing systems. |
The Motley Fool January 4, 2011 Tony Luckett |
Why Buy Berkshire Hathaway? Is Warren Buffett's company worth buying at the moment? |
Chemistry World October 14, 2013 Phillip Broadwith |
5000 jobs to be cut at Teva Israeli generics heavyweight Teva is accelerating its previously announced costcutting drive. |
Real Estate Portfolio Special Issue 2005 Jada A. Graves |
Spotlight on the Middle-East Israel may not be the first country that comes to mind when thinking about the global real estate market, but its real estate investment industry is in the early stages of a growth surge. |
The Motley Fool July 14, 2010 Jordan DiPietro |
Israeli Stocks You Can Actually Buy Finding Israeli stocks on U.S. indices can be difficult, so here's a start. |
The Motley Fool July 14, 2010 Alex Dumortier |
Berkshire Hathaway Is Extremely Cheap Here's your opportunity to own the ultimate blue chip. |
Entrepreneur August 2005 Mark Henricks |
Promised Land Working with an Israeli firm may not be as easy as dealing with one across town or even across the United States, but U.S. companies are finding new opportunities by partnering with Israeli firms. |
BusinessWeek January 17, 2005 |
Turkey And Israel Patch It Up Turkey and Israel are trying to mend relations strained by Turkish Prime Minister Recep Tayyip Erdogan's sharp criticism of Israeli actions in the Palestinian territories. |
The Motley Fool November 8, 2006 Brian Lawler |
Teva Is Rolling in Cash Again Investors, the bottom line is that with 13 proprietary drugs in phase 2 trials or later for some very large indications, plus 144 applications to sell generic versions of branded drugs waiting at the FDA, Teva's near-term future is strong. |
BusinessWeek October 7, 2010 Wainer & Ben-David |
The Controversy Over Israel's Business Elite With a few business owners controlling a huge part of the economy in Israel, cries for reform are getting louder. |
The Motley Fool April 23, 2007 Dave Mock |
Foolish Forecast: AT&T's Wireless Ways The telecommunications giant is set to report its first-quarter 2007 earnings results. Investors, here is what you can expect to find. |
The Motley Fool June 18, 2010 Morgan Housel |
Is Berkshire Hathaway a Buy? Historical valuations are about as low as they've ever been. The elephant acquisition, Burlington Northern, has already been bagged. And there's reason to believe insurance pricing could stage a rebound. |
The Motley Fool August 10, 2011 Matt Koppenheffer |
Partner Communications Shares Plunged: What You Need to Know Shares of Israeli cell-service provider Partner Communications were getting hung up on by investors today as shares fell as much as 22% in intraday trading on heavier-than-average volume. |
BusinessWeek February 23, 2004 Kripalani & Sandler |
Building Fences -- And Growing Closer From security to information technology, business ties between India and Israel are proliferating |
BusinessWeek November 3, 2003 Diane Brady |
Biotech: Teva's Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market. |
The Motley Fool August 15, 2007 Brian Orelli |
Buffett's Drug Deals During the most recent quarter Berkshire Hathaway has increased their holdings in several battered pharmaceutical and medical stocks. |
The Motley Fool July 25, 2005 Stephen D. Simpson |
Teva Tries to Buy Back the Top Spot $7.4 billion later, Teva Pharmaceuticals is poised to become the largest generics company in the world once again. Investors, take note. |
The Motley Fool November 9, 2006 Philip Durell |
The Best Blue Chip for 2007: Berkshire Hathaway Management doesn't get any better than Warren Buffett. It's hard to find a better lower-risk investment or a better blue chip than Berkshire Hathaway. |
The Motley Fool May 18, 2011 Jordan DiPietro |
Should You Buy and Hold Teva Pharmaceutical? The Israeli pharma firm passes all four of our retirement portfolio tests. |
The Motley Fool December 7, 2009 Jordan DiPietro |
Foreign Stocks You Can Actually Buy: Israel Finding foreign stocks on U.S. indices can be difficult. Here's a start. |
The Motley Fool December 6, 2011 Amitabha Chakraborty |
Can Noble's Israel Dream Come True? Noble Energy is exploring the idea of building an LNG terminal offshore Israel. |
The Motley Fool November 4, 2011 |
A Brief History of Berkshire Hathaway's Returns The decline in Berkshire's price-to-book value over the past year has been striking. Indeed, valuations fell far enough that Buffett began using Berkshire's cash to repurchase shares in September for the first time ever. |
Parameters Spring 2007 Louis Rene Beres |
Israel's Uncertain Strategic Future An assessment of current threats to Israel's survival along with recommendations for an end to its policy of nuclear ambiguity. |